Health News

FDA Approves Rx for Severe Aplastic Anemia
GlaxoSmithKline plc (GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta® (eltrombopag) in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).
Aspirin Effective for Clot Prevention in Certain Patients
New research suggests that aspirin may be a safe alternative for those who have to stop taking anti-blood-clotting medicines.
FDA Expands Approval of Rx for Rare Blood and Bone Disease
Earlier this year, the US Food and Drug Administration (FDA) gave a speedy approval to a new medication to treat a rare blood disease. Now, the FDA has expanded that approval.
Common Treatment for Pregnant Women May Be Ineffective
A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.
Reports Claim Drug Company Withheld Important Safety Information
The maker of a new anti-clotting medication may have withheld important safety information from regulators, according to several new reports.
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
HPV Shot Not Linked to Blood Clots
One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.
FDA Approves Belinostat for Rare Form of Non-Hodgkin Lymphoma
The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL).
Clot-Busting Therapy for Pulmonary Embolism Lowered Death Risk
Pulmonary embolism is a condition that can strike suddenly, sometimes with deadly consequences. New research on treatments for the condition could lead to better outcomes and understanding of risk factors.
Many Minority Kids With Cancer Missed Needed Medication
Children in remission from leukemia, the most common childhood cancer, need to take a certain medication to keep the cancer from coming back. But some of these children are not receiving all the medication they need.